Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome

被引:12
作者
Joo, Nam-Seok [2 ]
Kim, Kyu-Nam [2 ]
Kim, Kyung Soo [1 ]
机构
[1] Catholic Univ Korea, Dept Family Med, Seoul 137040, South Korea
[2] Ajou Univ, Sch Med, Dept Family Practice & Community Hlth, Suwon 441749, South Korea
关键词
CA-125; Metabolic Syndrome; Korean; BODY-MASS INDEX; OVARIAN-CANCER; EPITHELIAL OVARIAN; INSULIN-RESISTANCE; CA; 125; RISK; MORTALITY; OBESITY; ASSOCIATION; PROSTATE;
D O I
10.3346/jkms.2011.26.10.1328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum carbohydrate antigen 125 (CA-125) is a marker of ovarian cancer and obesity that is related with an increased risk of ovarian cancer. Obesity is a key factor of metabolic syndrome. We evaluated the relationship between CA-125 concentration and metabolic syndrome. The data from subjects who had any cancer and chronic infection were excluded. The data of 12,196 healthy Korean women were analyzed. After CA-125 concentration was divided by quartiles, the prevalence of metabolic syndrome and its components were compared. The lowest quartile of CA-125 compared with the highest quartile showed elevated values of most of metabolic parameters. In addition, as the quartile of CA-125 increased, metabolic derangement decreased. Increased numbers of metabolic syndrome components showed an inverse association with CA-125 levels (P < 0.001). The odds ratio (OR) for the lowest CA-125 quartile vs the highest CA-125 quartile significantly increased in the presence of metabolic syndrome (OR = 1.202, 95% Confidence Interval [CI] 1.013-1.423), elevated triglyceride (OR = 1.381, 95% CI 1.167-1.633), and low high-density lipoprotein cholesterol (OR = 1.168, 95% CI 1.039-1.312). The presence of metabolic syndrome, elevated triglyceride, or low high-density lipoprotein cholesterol negatively correlates with CA-125 concentration.
引用
收藏
页码:1328 / 1332
页数:5
相关论文
共 50 条
  • [31] Serum CA125 Level Is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes
    Yao, Litong
    Zhong, Yifan
    He, Lingzi
    Wang, Yan
    Wu, Jingyang
    Geng, Jin
    Zhou, Yun
    Zhang, Jiahua
    Chen, Jun
    Shan, Zhongyan
    Teng, Weiping
    Xu, Yingying
    Chen, Lei
    Liu, Lei
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 1803 - 1812
  • [32] The Relationship Between Serum Uric Acid Concentration and Metabolic Syndrome in University Freshmen
    Lin, Kuan-Pin
    JOURNAL OF NURSING RESEARCH, 2009, 17 (04) : 286 - 292
  • [33] Epidemiologic and biologic correlates of serum HE4 and CA125 in women from the National Health and Nutritional Survey (NHANES)
    Cramer, Daniel W.
    Vitonis, Allison F.
    Sasamoto, Naoko
    Yamamoto, Hidemi
    Fichorova, Raina N.
    GYNECOLOGIC ONCOLOGY, 2021, 161 (01) : 282 - 290
  • [34] Inverse correlation of serum inflammatory markers with metabolic parameters in healthy, Black and White prepubertal youth
    Zabaleta, J.
    Velasco-Gonzalez, C.
    Estrada, J.
    Ravussin, E.
    Pelligrino, N.
    Mohler, M. C.
    Larson-Meyer, E.
    Boulares, A. H.
    Powell-Young, Y.
    Bennett, B.
    Happel, K.
    Cefalu, W.
    Scribner, R.
    Tseng, T-S
    Sothern, M.
    INTERNATIONAL JOURNAL OF OBESITY, 2014, 38 (04) : 563 - 568
  • [35] Usefulness of determination of CA125 concentration as a marker for ovarian tumours with special consideration of ovarian endometriotic cysts
    Wojcik-Krowiranda, Katarzyna
    Litwinska, Magdalena
    Bienkiewicz, Andrzej
    PRZEGLAD MENOPAUZALNY, 2010, 9 (06): : 362 - 365
  • [36] Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study
    Hu, Xiao
    Zhang, Jingzhou
    Cao, Yu
    BMC CANCER, 2022, 22 (01)
  • [37] Label-free electrochemical immunosensor for detection of oncomarker CA125 in serum
    Honorato de Castro, Ana Cristina
    Alves, Livia Maria
    Silva Siquieroli, Ana Carolina
    Madurro, Joao Marcos
    Brito-Madurro, Ana Graci
    MICROCHEMICAL JOURNAL, 2020, 155
  • [38] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Baron, AT
    Maihle, N
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 288 - 289
  • [39] Ovarian thecoma with ascites and high serum levels of CA125
    Takemori, M
    Nishimura, R
    Hasegawa, K
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2000, 264 (01) : 42 - 44
  • [40] Ovarian thecoma with ascites and high serum levels of CA125
    M. Takemori
    Ryuichiro Nishimura
    Kazuo Hasegawa
    Archives of Gynecology and Obstetrics, 2000, 264 : 42 - 44